Washington - The optimum doses of biologic treatments for psoriasis may be higher than previously believed, according to Mark Lebwohl, M.D., professor and chairman, department of dermatology, Mt. Sinai School of Medicine.
Reviewing Late-Breaking Research From AAD 2024
ReV Up Your Vitiligo Treatment Strategies
Amy Spizuoco, DO, FAOCD: Addressing STDs and Utilizing Dermatopathology With Care in Diverse Patient Populations
The Cutaneous Connection: Splish, Splash, AD Management Starts in the Bath
Melanoma and the Wrong Site
Tunlametinib Wins Approval in China for NRAS+ Advanced Melanoma After PD-1/PD-L1 Therapy